Next Article in Journal
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
Next Article in Special Issue
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation
Previous Article in Journal
Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity
Previous Article in Special Issue
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
 
 
Brief Report

Article Versions Notes

Vaccines 2022, 10(4), 613; https://doi.org/10.3390/vaccines10040613
Action Date Notes Link
article xml file uploaded 14 April 2022 14:38 CEST Original file -
article xml uploaded. 14 April 2022 14:38 CEST Update https://www.mdpi.com/2076-393X/10/4/613/xml
article pdf uploaded. 14 April 2022 14:38 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/613/pdf
article html file updated 14 April 2022 14:39 CEST Original file -
article html file updated 2 August 2022 19:00 CEST Update https://www.mdpi.com/2076-393X/10/4/613/html
Back to TopTop